Andreas Kluge
Gründer bei TELIX PHARMACEUTICALS LIMITED
Vermögen: 222 Mio $ am 30.04.2024
Aktive Positionen von Andreas Kluge
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 03.01.2017 | - |
| Gründer | 01.11.2015 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 03.01.2017 | 02.06.2020 | |
Therapeia GmbH & Co. Kg
 Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Vorstandsvorsitzender | 01.01.2007 | - |
| Gründer | 01.01.2007 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 | - | |
| ABX-CRO advanced pharmaceutical services | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2002 | - |
| Gründer | 01.08.2002 | - |
Karriereverlauf von Andreas Kluge
Ehemalige bekannte Positionen von Andreas Kluge
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ABX advanced biochemical compounds GmbH
 ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Vorstandsvorsitzender | 01.09.1996 | 01.07.2002 |
| Gründer | 01.09.1996 | 01.07.2002 |
Ausbildung von Andreas Kluge
| Freie Universität Berlin | Doctorate Degree |
Statistik
International
| Deutschland | 5 |
| Australien | 2 |
Operativ
| Founder | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Health Technology |
| ABX-CRO advanced pharmaceutical services | |
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Process Industries |
- Börse
- Insiders
- Andreas Kluge
- Erfahrung
